Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Alglucosidase Alfa · Lumizyme, Myozyme

Recombinant protein · Protein replacement · developed by Genzyme

Approved FDA, Apr 2006
SNY Developer
1 Registered trials

What is Alglucosidase Alfa?

Alglucosidase alfa is a recombinant lysosomal enzyme that provides an exogenous source of acid alpha-glucosidase (GAA). It is taken up through mannose-6-phosphate receptors into lysosomes, where it cleaves glycogen. It is studied in glycogen storage disease type II (Pompe disease).

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
Lumizyme, Myozyme, GZ419829
Drug type
Recombinant protein
Mechanism
Protein replacement
Pathways
mannose-6-phosphate receptor-mediated uptake into lysosomes, lysosomal glycogen cleavage
Therapy area
Neurology
Developer
Genzyme (SNY)
FDA status
Approved as Lumizyme, Myozyme (April 28, 2006), BLA125141 · FDA label
UNII
DTI67O9503

✅ FDA-approved uses

From the indications section of the FDA label (version of Jan 10, 2025). Read the full label for the exact wording, limitations and safety information.

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT04848779 N/A Glycogen Storage Disease Type II Completed SNY

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Glycogen Storage Disease Type II

More from Genzyme

Sources

Updated Nov 15, 2026. Something wrong or missing? Report it on the SNY page.

Follow SNY, the company behind Alglucosidase Alfa

See SNY's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.

SNY catalysts and pipeline →
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.